BIOMAT Database Logo BIOMAT Database Logo

An uncontrolled study with thiopropazate in the treatment of persistent dyskinesia. 1977

J V Ananth, and T A Ban, and H E Lehmann

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009069 Movement Disorders Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions. Dyskinesia Syndromes,Etat Marbre,Status Marmoratus,Movement Disorder Syndromes,Dyskinesia Syndrome,Movement Disorder,Movement Disorder Syndrome
D010640 Phenothiazines Compounds containing dibenzo-1,4-thiazine. Some of them are neuroactive.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

J V Ananth, and T A Ban, and H E Lehmann
Thiopropazate hydrochloride in persistent dyskinesia.
October 1971, British medical journal,
J V Ananth, and T A Ban, and H E Lehmann
Thiopropazate hydrochloride in persistent dyskinesia.
December 1971, British medical journal,
J V Ananth, and T A Ban, and H E Lehmann
Management of tardive dyskinesia with thiopropazate.
August 1973, The American journal of psychiatry,
J V Ananth, and T A Ban, and H E Lehmann
Six month evaluation of thiopropazate hydrochloride in tardive dyskinesia.
June 1979, Journal of neurology, neurosurgery, and psychiatry,
J V Ananth, and T A Ban, and H E Lehmann
Comparison of thiopropazate and trifluoperazine on oral dyskinesia - a double blind study.
September 1974, Current therapeutic research, clinical and experimental,
J V Ananth, and T A Ban, and H E Lehmann
PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
March 1965, Lancet (London, England),
J V Ananth, and T A Ban, and H E Lehmann
PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
March 1965, Lancet (London, England),
J V Ananth, and T A Ban, and H E Lehmann
PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
May 1965, Lancet (London, England),
J V Ananth, and T A Ban, and H E Lehmann
PERSISTENT ORAL DYSKINESIA IN TREATMENT WITH PHENOTHIAZINE DERIVATIVES.
February 1965, Lancet (London, England),
J V Ananth, and T A Ban, and H E Lehmann
Treatment of tardive dyskinesia. II. Short-term efficacy of dopamine-blocking agents haloperidol and thiopropazate.
July 1972, Archives of general psychiatry,
Copied contents to your clipboard!